Cyclo Therapeutics Signs Master Services Agreement With Worldwide Clinical Trials
By, Admin1 min read
Share
Cyclo Therapeutics, Inc., A Clinical-Stage Biotechnology Company That Develops Cyclodextrin-Based Products For The Treatment Of Niemann-Pick Disease Type C (Npc) And Alzheimer
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
